Rockefeller Capital Management’s CervoMed CRVO Stock Holding History

Rockefeller Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40	Buy	+13	New	+$46	﹤0.01%	4699

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Rockefeller Capital Management's CRVO Position: Q2 2026 in Review

Rockefeller Capital Management opened a new position in CervoMed (CRVO) in Q2 2026: 13 shares worth $40. The stake represents ﹤0.01% of the portfolio and ranks #4699 among its holdings.

37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Rockefeller Capital Management held 13 shares of CervoMed worth $40 as of Q2 2026.
CervoMed was a new Rockefeller Capital Management position in Q2 2026.
CervoMed made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4699 holding.
37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.